Industry Research Reports

Home > Reports > Service & Software > Global AI Target Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2032

Global AI Target Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Service & Software

Published Date: 2026-07-24

Pages: 156 Pages

Report ld: 6980932

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

AI Target Discovery Platform Market Size(US$)

CAGR 2026-2032

25.0%

Market Size,2032

USD 3,147

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 825 million

Market Forecast in 2032(Value)

US$ 3,147 million

CAGR

25.0%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global AI Target Discovery Platform market is projected to grow from US$ 654 million in 2025 to US$ 3147 million by 2032, at a CAGR of 25.0% (2026-2032), driven by critical product segments and diverse end‑use applications.

An AI target discovery platform is a computational software platform or technology service for early drug discovery. It integrates multi-omics, single-cell, spatial, clinical phenotype, genetic variant, literature knowledge graph and experimental data, and uses machine learning, causal inference, knowledge graphs, natural language processing and multimodal models to identify disease-relevant targets, rank target candidates and deliver evidence packages, druggability, safety and validation suggestions. It is mainly used by pharmaceutical companies, biotech companies and research institutions for novel target discovery, target validation, indication expansion and biomarker research, with an estimated blended gross margin of approximately 65%.

Demand is mainly driven by pharmaceutical and biotech companies seeking to improve early discovery hit rates, shorten target screening cycles and reduce downstream clinical failure risk. Complex diseases, rare diseases, immuno-oncology, neurodegeneration and inflammatory diseases create strong demand for new targets and interpretable evidence packages, while customers increasingly assess whether platforms can convert public datasets, internal omics data and real-world evidence into testable hypotheses.

Product development is moving from standalone literature mining or differential omics analysis toward multimodal foundation models, causal networks, knowledge graphs, virtual cells, digital twins and automated experimental feedback loops. Supply models include SaaS subscriptions, enterprise deployment, API data services and collaborative discovery projects. Leading providers usually combine target identification, prioritization, druggability assessment, mechanism explanation and validation experiment design, with differentiation centered on proprietary data scale, model interpretability and wet-lab validation capability.

Regional demand remains led by large pharmaceutical customers in North America and Europe, while Asia-Pacific is growing faster with local innovative drug pipelines, AI infrastructure and pharma collaboration programs. Key risks include biological data bias, model generalization, intellectual property ownership and validation cost, while opportunities come from integration with single-cell sequencing, spatial omics, proteomics, CRO validation services and downstream drug design platforms.

MARKET SEGMENTATION

By Company

Insilico Medicine
Recursion
Owkin
BenevolentAI
CytoReason
Aitia
Turbine
Variant Bio
Deep Genomics
Healx
Relation Therapeutics
Causaly
FRONTEO
BioMap
Standigm
XtalPi

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

SaaS Software Platform
Enterprise-Deployed Platform
Collaborative Discovery Service
Data/API Subscription
Integrated AI + Wet-Lab Service

Segment by Application

Pharma Discovery Programs
Biotech Pipeline Development
Academic Translational Research
CRO and Discovery Services
Clinical Research and Precision Medicine
Government and Nonprofit Research
Others

Segment by Category

Multi-Omics Data Platform
Knowledge Graph and Literature Platform
Patient and Clinical Data Platform
Single-Cell and Spatial Data Platform
Genomics and Variant Platform
Integrated Multimodal Data Platform

Segment by Division

Target Identification Platform
Target Prioritization Platform
Target Validation Support Platform
Biomarker Co-Discovery Platform
Drug Repositioning Platform
Mechanism-of-Action Modeling Platform

biaoTi REPORT SCOPE

This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global AI Target Discovery Platform market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the AI Target Discovery Platform study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential

Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves

Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application

Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers

Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers

Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas

Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges

Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles

Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments

Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels

Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to AI Target Discovery Platform: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global AI Target Discovery Platform Market Size by Type, 2021 vs 2025 vs 2032

1.2.2 SaaS Software Platform

1.2.3 Enterprise-Deployed Platform

1.2.4 Collaborative Discovery Service

1.2.5 Data/API Subscription

1.2.6 Integrated AI + Wet-Lab Service

1.3 Market Segmentation by Data Foundation

1.3.1 Global AI Target Discovery Platform Market Size by Data Foundation, 2021 vs 2025 vs 2032

1.3.2 Multi-Omics Data Platform

1.3.3 Knowledge Graph and Literature Platform

1.3.4 Patient and Clinical Data Platform

1.3.5 Single-Cell and Spatial Data Platform

1.3.6 Genomics and Variant Platform

1.3.7 Integrated Multimodal Data Platform

1.4 Market Segmentation by Analytical Function

1.4.1 Global AI Target Discovery Platform Market Size by Analytical Function, 2021 vs 2025 vs 2032

1.4.2 Target Identification Platform

1.4.3 Target Prioritization Platform

1.4.4 Target Validation Support Platform

1.4.5 Biomarker Co-Discovery Platform

1.4.6 Drug Repositioning Platform

1.4.7 Mechanism-of-Action Modeling Platform

1.5 Market Segmentation by Project Scope

1.5.1 Global AI Target Discovery Platform Market Size by Project Scope, 2021 vs 2025 vs 2032

1.5.2 Target Discovery Only

1.5.3 Target-to-Hit Discovery

1.5.4 Target-to-Lead Discovery

1.5.5 End-to-End Preclinical Discovery

1.5.6 Target and Biomarker Package

1.6 Market Segmentation by Application

1.6.1 Global AI Target Discovery Platform Market Size by Application, 2021 vs 2025 vs 2032

1.6.2 Pharma Discovery Programs

1.6.3 Biotech Pipeline Development

1.6.4 Academic Translational Research

1.6.5 CRO and Discovery Services

1.6.6 Clinical Research and Precision Medicine

1.6.7 Government and Nonprofit Research

1.6.8 Others

1.7 Assumptions and Limitations

1.8 Study Objectives

1.9 Years Considered

2 Executive Summary

2.1 Global AI Target Discovery Platform Revenue Estimates and Forecasts (2021-2032)

2.2 Global AI Target Discovery Platform Revenue by Region

2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032

2.2.2 Historical and Forecasted Revenue by Region (2021-2032)

2.2.3 Global Revenue-Based Market Share by Region (2021-2032)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape

3.1 Global AI Target Discovery Platform Players’ Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2021-2026)

3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Players (2021 vs 2025)

3.2 Global AI Target Discovery Platform Companies Headquarters and Service Footprint

3.3 Key Player Market Share by Product Type

3.3.1 SaaS Software Platform: Market Share by Key Players

3.3.2 Enterprise-Deployed Platform: Market Share by Key Players

3.3.3 Collaborative Discovery Service: Market Share by Key Players

3.3.4 Data/API Subscription: Market Share by Key Players

3.3.5 Integrated AI + Wet-Lab Service: Market Share by Key Players

3.4 Global AI Target Discovery Platform Market Concentration and Dynamics

3.4.1 Global Market Concentration

3.4.2 Market Entry and Exit Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation

4.1 Global AI Target Discovery Platform Market by Type

4.1.1 Global Revenue by Type (2021-2032)

4.1.2 Global Revenue-Based Market Share by Type (2021-2032)

4.2 Global AI Target Discovery Platform Market by Data Foundation

4.2.1 Global Revenue by Data Foundation (2021-2032)

4.2.2 Global Revenue-Based Market Share by Data Foundation (2021-2032)

4.3 Global AI Target Discovery Platform Market by Analytical Function

4.3.1 Global Revenue by Analytical Function (2021-2032)

4.3.2 Global Revenue-Based Market Share by Analytical Function (2021-2032)

4.4 Global AI Target Discovery Platform Market by Project Scope

4.4.1 Global Revenue by Project Scope (2021-2032)

4.4.2 Global Revenue-Based Market Share by Project Scope (2021-2032)

4.5 Key Product Attributes and Differentiation

4.6 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.6.1 High-Growth Niches and Adoption Drivers

4.6.2 Profitability Hotspots and Cost Drivers

4.6.3 Substitution Threats

5 Downstream Applications and Customers

5.1 Global AI Target Discovery Platform Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)

5.1.2 Revenue-Based Market Share by Application (2021-2032)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2021-2032)

6.2 North America Key Players’ Revenue in 2025

6.3 North America AI Target Discovery Platform Market Size by Application (2021-2032)

6.4 North America Growth Accelerators and Market Barriers

6.5 North America AI Target Discovery Platform Market Size by Country

6.5.1 North America Revenue Trends by Country

6.5.2 US

6.5.3 Canada

6.5.4 Mexico

7 Europe

7.1 Europe Market Size (2021-2032)

7.2 Europe Key Players’ Revenue in 2025

7.3 Europe AI Target Discovery Platform Market Size by Application (2021-2032)

7.4 Europe Growth Accelerators and Market Barriers

7.5 Europe AI Target Discovery Platform Market Size by Country

7.5.1 Europe Revenue Trends by Country

7.5.2 Germany

7.5.3 France

7.5.4 U.K.

7.5.5 Italy

7.5.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2021-2032)

8.2 Asia-Pacific Key Players’ Revenue in 2025

8.3 Asia-Pacific AI Target Discovery Platform Market Size by Application (2021-2032)

8.4 Asia-Pacific Growth Accelerators and Market Barriers

8.5 Asia-Pacific AI Target Discovery Platform Market Size by Region

8.5.1 Asia-Pacific Revenue Trends by Region

8.6 China

8.7 Japan

8.8 South Korea

8.9 Australia

8.10 India

8.11 Southeast Asia

8.11.1 Indonesia

8.11.2 Vietnam

8.11.3 Malaysia

8.11.4 Philippines

8.11.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2021-2032)

9.2 Central and South America Key Players’ Revenue in 2025

9.3 Central and South America AI Target Discovery Platform Market Size by Application (2021-2032)

9.4 Central and South America Investment Opportunities and Key Challenges

9.5 Central and South America AI Target Discovery Platform Market Size by Country

9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)

9.5.2 Brazil

9.5.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2021-2032)

10.2 Middle East and Africa Key Players’ Revenue in 2025

10.3 Middle East and Africa AI Target Discovery Platform Market Size by Application (2021-2032)

10.4 Middle East and Africa Investment Opportunities and Key Challenges

10.5 Middle East and Africa AI Target Discovery Platform Market Size by Country

10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)

10.5.2 GCC Countries

10.5.3 Israel

10.5.4 Egypt

10.5.5 South Africa

11 Corporate Profile

11.1 Insilico Medicine

11.1.1 Insilico Medicine Corporation Information

11.1.2 Insilico Medicine Business Overview

11.1.3 Insilico Medicine AI Target Discovery Platform Product Features and Attributes

11.1.4 Insilico Medicine AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.1.5 Insilico Medicine AI Target Discovery Platform Revenue by Product in 2025

11.1.6 Insilico Medicine AI Target Discovery Platform Revenue by Application in 2025

11.1.7 Insilico Medicine AI Target Discovery Platform Revenue by Geographic Area in 2025

11.1.8 Insilico Medicine AI Target Discovery Platform SWOT Analysis

11.1.9 Insilico Medicine Recent Developments

11.2 Recursion

11.2.1 Recursion Corporation Information

11.2.2 Recursion Business Overview

11.2.3 Recursion AI Target Discovery Platform Product Features and Attributes

11.2.4 Recursion AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.2.5 Recursion AI Target Discovery Platform Revenue by Product in 2025

11.2.6 Recursion AI Target Discovery Platform Revenue by Application in 2025

11.2.7 Recursion AI Target Discovery Platform Revenue by Geographic Area in 2025

11.2.8 Recursion AI Target Discovery Platform SWOT Analysis

11.2.9 Recursion Recent Developments

11.3 Owkin

11.3.1 Owkin Corporation Information

11.3.2 Owkin Business Overview

11.3.3 Owkin AI Target Discovery Platform Product Features and Attributes

11.3.4 Owkin AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.3.5 Owkin AI Target Discovery Platform Revenue by Product in 2025

11.3.6 Owkin AI Target Discovery Platform Revenue by Application in 2025

11.3.7 Owkin AI Target Discovery Platform Revenue by Geographic Area in 2025

11.3.8 Owkin AI Target Discovery Platform SWOT Analysis

11.3.9 Owkin Recent Developments

11.4 BenevolentAI

11.4.1 BenevolentAI Corporation Information

11.4.2 BenevolentAI Business Overview

11.4.3 BenevolentAI AI Target Discovery Platform Product Features and Attributes

11.4.4 BenevolentAI AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.4.5 BenevolentAI AI Target Discovery Platform Revenue by Product in 2025

11.4.6 BenevolentAI AI Target Discovery Platform Revenue by Application in 2025

11.4.7 BenevolentAI AI Target Discovery Platform Revenue by Geographic Area in 2025

11.4.8 BenevolentAI AI Target Discovery Platform SWOT Analysis

11.4.9 BenevolentAI Recent Developments

11.5 CytoReason

11.5.1 CytoReason Corporation Information

11.5.2 CytoReason Business Overview

11.5.3 CytoReason AI Target Discovery Platform Product Features and Attributes

11.5.4 CytoReason AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.5.5 CytoReason AI Target Discovery Platform Revenue by Product in 2025

11.5.6 CytoReason AI Target Discovery Platform Revenue by Application in 2025

11.5.7 CytoReason AI Target Discovery Platform Revenue by Geographic Area in 2025

11.5.8 CytoReason AI Target Discovery Platform SWOT Analysis

11.5.9 CytoReason Recent Developments

11.6 Aitia

11.6.1 Aitia Corporation Information

11.6.2 Aitia Business Overview

11.6.3 Aitia AI Target Discovery Platform Product Features and Attributes

11.6.4 Aitia AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.6.5 Aitia Recent Developments

11.7 Turbine

11.7.1 Turbine Corporation Information

11.7.2 Turbine Business Overview

11.7.3 Turbine AI Target Discovery Platform Product Features and Attributes

11.7.4 Turbine AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.7.5 Turbine Recent Developments

11.8 Variant Bio

11.8.1 Variant Bio Corporation Information

11.8.2 Variant Bio Business Overview

11.8.3 Variant Bio AI Target Discovery Platform Product Features and Attributes

11.8.4 Variant Bio AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.8.5 Variant Bio Recent Developments

11.9 Deep Genomics

11.9.1 Deep Genomics Corporation Information

11.9.2 Deep Genomics Business Overview

11.9.3 Deep Genomics AI Target Discovery Platform Product Features and Attributes

11.9.4 Deep Genomics AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.9.5 Deep Genomics Recent Developments

11.10 Healx

11.10.1 Healx Corporation Information

11.10.2 Healx Business Overview

11.10.3 Healx AI Target Discovery Platform Product Features and Attributes

11.10.4 Healx AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.10.5 Company Ten Recent Developments

11.11 Relation Therapeutics

11.11.1 Relation Therapeutics Corporation Information

11.11.2 Relation Therapeutics Business Overview

11.11.3 Relation Therapeutics AI Target Discovery Platform Product Features and Attributes

11.11.4 Relation Therapeutics AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.11.5 Relation Therapeutics Recent Developments

11.12 Causaly

11.12.1 Causaly Corporation Information

11.12.2 Causaly Business Overview

11.12.3 Causaly AI Target Discovery Platform Product Features and Attributes

11.12.4 Causaly AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.12.5 Causaly Recent Developments

11.13 FRONTEO

11.13.1 FRONTEO Corporation Information

11.13.2 FRONTEO Business Overview

11.13.3 FRONTEO AI Target Discovery Platform Product Features and Attributes

11.13.4 FRONTEO AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.13.5 FRONTEO Recent Developments

11.14 BioMap

11.14.1 BioMap Corporation Information

11.14.2 BioMap Business Overview

11.14.3 BioMap AI Target Discovery Platform Product Features and Attributes

11.14.4 BioMap AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.14.5 BioMap Recent Developments

11.15 Standigm

11.15.1 Standigm Corporation Information

11.15.2 Standigm Business Overview

11.15.3 Standigm AI Target Discovery Platform Product Features and Attributes

11.15.4 Standigm AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.15.5 Standigm Recent Developments

11.16 XtalPi

11.16.1 XtalPi Corporation Information

11.16.2 XtalPi Business Overview

11.16.3 XtalPi AI Target Discovery Platform Product Features and Attributes

11.16.4 XtalPi AI Target Discovery Platform Revenue and Gross Margin (2021-2026)

11.16.5 XtalPi Recent Developments

12 AI Target Discovery Platform Value Chain and Ecosystem Analysis

12.1 AI Target Discovery Platform Value Chain (Ecosystem Structure)

12.2 Upstream Analysis

12.2.1 Key Technologies, Platforms and Infrastructure

12.3 Midstream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 AI Target Discovery Platform Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global AI Target Discovery Platform Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global AI Target Discovery Platform Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Table 2. Global AI Target Discovery Platform Market Size Growth Rate by Data Foundation, 2021 vs 2025 vs 2032 (US$ Million)

Table 3. Global AI Target Discovery Platform Market Size Growth Rate by Analytical Function, 2021 vs 2025 vs 2032 (US$ Million)

Table 4. Global AI Target Discovery Platform Market Size Growth Rate by Project Scope, 2021 vs 2025 vs 2032 (US$ Million)

Table 5. Global AI Target Discovery Platform Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Table 6. Global AI Target Discovery Platform Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 7. Global AI Target Discovery Platform Revenue by Region (US$ Million), 2021-2026

Table 8. Global AI Target Discovery Platform Revenue by Region (US$ Million), 2027-2032

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 10. Global AI Target Discovery Platform Revenue by Players (US$ Million), 2021-2026

Table 11. Global AI Target Discovery Platform Revenue-Based Market Share by Players (2021-2026)

Table 12. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)

Table 13. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on AI Target Discovery Platform Revenue, 2025

Table 14. Global AI Target Discovery Platform Average Gross Margin (%) by Player (2021 vs 2025)

Table 15. Global AI Target Discovery Platform Companies Headquarters

Table 16. Global AI Target Discovery Platform Market Concentration Ratio (CR5)

Table 17. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis

Table 18. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 19. Global AI Target Discovery Platform Revenue by Type (US$ Million), 2021-2026

Table 20. Global AI Target Discovery Platform Revenue by Type (US$ Million), 2027-2032

Table 21. Global AI Target Discovery Platform Revenue by Data Foundation (US$ Million), 2021-2026

Table 22. Global AI Target Discovery Platform Revenue by Data Foundation (US$ Million), 2027-2032

Table 23. Global AI Target Discovery Platform Revenue by Analytical Function (US$ Million), 2021-2026

Table 24. Global AI Target Discovery Platform Revenue by Analytical Function (US$ Million), 2027-2032

Table 25. Global AI Target Discovery Platform Revenue by Project Scope (US$ Million), 2021-2026

Table 26. Global AI Target Discovery Platform Revenue by Project Scope (US$ Million), 2027-2032

Table 27. Key Product Attributes and Differentiation

Table 28. Global AI Target Discovery Platform Revenue by Application (US$ Million), 2021-2026

Table 29. Global AI Target Discovery Platform Revenue by Application (US$ Million), 2027-2032

Table 30. AI Target Discovery Platform High-Growth Sectors Demand CAGR (2026-2032)

Table 31. Top Customers by Region

Table 32. Top Customers by Application

Table 33. North America AI Target Discovery Platform Growth Accelerators and Market Barriers

Table 34. North America AI Target Discovery Platform Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 35. Europe AI Target Discovery Platform Growth Accelerators and Market Barriers

Table 36. Europe AI Target Discovery Platform Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia-Pacific AI Target Discovery Platform Growth Accelerators and Market Barriers

Table 38. Asia-Pacific AI Target Discovery Platform Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 39. Central and South America AI Target Discovery Platform Investment Opportunities and Key Challenges

Table 40. Central and South America AI Target Discovery Platform Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 41. Middle East and Africa AI Target Discovery Platform Investment Opportunities and Key Challenges

Table 42. Middle East and Africa AI Target Discovery Platform Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 43. Insilico Medicine Corporation Information

Table 44. Insilico Medicine Description and Major Businesses

Table 45. Insilico Medicine Product Features and Attributes

Table 46. Insilico Medicine Revenue (US$ Million) and Gross Margin (2021-2026)

Table 47. Insilico Medicine Revenue Proportion by Product in 2025

Table 48. Insilico Medicine Revenue Proportion by Application in 2025

Table 49. Insilico Medicine Revenue Proportion by Geographic Area in 2025

Table 50. Insilico Medicine AI Target Discovery Platform SWOT Analysis

Table 51. Insilico Medicine Recent Developments

Table 52. Recursion Corporation Information

Table 53. Recursion Description and Major Businesses

Table 54. Recursion Product Features and Attributes

Table 55. Recursion Revenue (US$ Million) and Gross Margin (2021-2026)

Table 56. Recursion Revenue Proportion by Product in 2025

Table 57. Recursion Revenue Proportion by Application in 2025

Table 58. Recursion Revenue Proportion by Geographic Area in 2025

Table 59. Recursion AI Target Discovery Platform SWOT Analysis

Table 60. Recursion Recent Developments

Table 61. Owkin Corporation Information

Table 62. Owkin Description and Major Businesses

Table 63. Owkin Product Features and Attributes

Table 64. Owkin Revenue (US$ Million) and Gross Margin (2021-2026)

Table 65. Owkin Revenue Proportion by Product in 2025

Table 66. Owkin Revenue Proportion by Application in 2025

Table 67. Owkin Revenue Proportion by Geographic Area in 2025

Table 68. Owkin AI Target Discovery Platform SWOT Analysis

Table 69. Owkin Recent Developments

Table 70. BenevolentAI Corporation Information

Table 71. BenevolentAI Description and Major Businesses

Table 72. BenevolentAI Product Features and Attributes

Table 73. BenevolentAI Revenue (US$ Million) and Gross Margin (2021-2026)

Table 74. BenevolentAI Revenue Proportion by Product in 2025

Table 75. BenevolentAI Revenue Proportion by Application in 2025

Table 76. BenevolentAI Revenue Proportion by Geographic Area in 2025

Table 77. BenevolentAI AI Target Discovery Platform SWOT Analysis

Table 78. BenevolentAI Recent Developments

Table 79. CytoReason Corporation Information

Table 80. CytoReason Description and Major Businesses

Table 81. CytoReason Product Features and Attributes

Table 82. CytoReason Revenue (US$ Million) and Gross Margin (2021-2026)

Table 83. CytoReason Revenue Proportion by Product in 2025

Table 84. CytoReason Revenue Proportion by Application in 2025

Table 85. CytoReason Revenue Proportion by Geographic Area in 2025

Table 86. CytoReason AI Target Discovery Platform SWOT Analysis

Table 87. CytoReason Recent Developments

Table 88. Aitia Corporation Information

Table 89. Aitia Description and Major Businesses

Table 90. Aitia Product Features and Attributes

Table 91. Aitia Revenue (US$ Million) and Gross Margin (2021-2026)

Table 92. Aitia Recent Developments

Table 93. Turbine Corporation Information

Table 94. Turbine Description and Major Businesses

Table 95. Turbine Product Features and Attributes

Table 96. Turbine Revenue (US$ Million) and Gross Margin (2021-2026)

Table 97. Turbine Recent Developments

Table 98. Variant Bio Corporation Information

Table 99. Variant Bio Description and Major Businesses

Table 100. Variant Bio Product Features and Attributes

Table 101. Variant Bio Revenue (US$ Million) and Gross Margin (2021-2026)

Table 102. Variant Bio Recent Developments

Table 103. Deep Genomics Corporation Information

Table 104. Deep Genomics Description and Major Businesses

Table 105. Deep Genomics Product Features and Attributes

Table 106. Deep Genomics Revenue (US$ Million) and Gross Margin (2021-2026)

Table 107. Deep Genomics Recent Developments

Table 108. Healx Corporation Information

Table 109. Healx Description and Major Businesses

Table 110. Healx Product Features and Attributes

Table 111. Healx Revenue (US$ Million) and Gross Margin (2021-2026)

Table 112. Healx Recent Developments

Table 113. Relation Therapeutics Corporation Information

Table 114. Relation Therapeutics Description and Major Businesses

Table 115. Relation Therapeutics Product Features and Attributes

Table 116. Relation Therapeutics Revenue (US$ Million) and Gross Margin (2021-2026)

Table 117. Relation Therapeutics Recent Developments

Table 118. Causaly Corporation Information

Table 119. Causaly Description and Major Businesses

Table 120. Causaly Product Features and Attributes

Table 121. Causaly Revenue (US$ Million) and Gross Margin (2021-2026)

Table 122. Causaly Recent Developments

Table 123. FRONTEO Corporation Information

Table 124. FRONTEO Description and Major Businesses

Table 125. FRONTEO Product Features and Attributes

Table 126. FRONTEO Revenue (US$ Million) and Gross Margin (2021-2026)

Table 127. FRONTEO Recent Developments

Table 128. BioMap Corporation Information

Table 129. BioMap Description and Major Businesses

Table 130. BioMap Product Features and Attributes

Table 131. BioMap Revenue (US$ Million) and Gross Margin (2021-2026)

Table 132. BioMap Recent Developments

Table 133. Standigm Corporation Information

Table 134. Standigm Description and Major Businesses

Table 135. Standigm Product Features and Attributes

Table 136. Standigm Revenue (US$ Million) and Gross Margin (2021-2026)

Table 137. Standigm Recent Developments

Table 138. XtalPi Corporation Information

Table 139. XtalPi Description and Major Businesses

Table 140. XtalPi Product Features and Attributes

Table 141. XtalPi Revenue (US$ Million) and Gross Margin (2021-2026)

Table 142. XtalPi Recent Developments

Table 143. Technologies, Platforms and Infrastructure

Table 144. Distributors List

Table 145. Market Trends and Market Evolution

Table 146. Market Drivers and Opportunities

Table 147. Market Challenges, Risks, and Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Global AI Target Discovery Platform Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Figure 2. SaaS Software Platform Product Picture

Figure 3. Enterprise-Deployed Platform Product Picture

Figure 4. Collaborative Discovery Service Product Picture

Figure 5. Data/API Subscription Product Picture

Figure 6. Integrated AI + Wet-Lab Service Product Picture

Figure 7. Global AI Target Discovery Platform Market Size Growth Rate by Data Foundation, 2021 vs 2025 vs 2032 (US$ Million)

Figure 8. Multi-Omics Data Platform Product Picture

Figure 9. Knowledge Graph and Literature Platform Product Picture

Figure 10. Patient and Clinical Data Platform Product Picture

Figure 11. Single-Cell and Spatial Data Platform Product Picture

Figure 12. Genomics and Variant Platform Product Picture

Figure 13. Integrated Multimodal Data Platform Product Picture

Figure 14. Global AI Target Discovery Platform Market Size Growth Rate by Analytical Function, 2021 vs 2025 vs 2032 (US$ Million)

Figure 15. Target Identification Platform Product Picture

Figure 16. Target Prioritization Platform Product Picture

Figure 17. Target Validation Support Platform Product Picture

Figure 18. Biomarker Co-Discovery Platform Product Picture

Figure 19. Drug Repositioning Platform Product Picture

Figure 20. Mechanism-of-Action Modeling Platform Product Picture

Figure 21. Global AI Target Discovery Platform Market Size Growth Rate by Project Scope, 2021 vs 2025 vs 2032 (US$ Million)

Figure 22. Target Discovery Only Product Picture

Figure 23. Target-to-Hit Discovery Product Picture

Figure 24. Target-to-Lead Discovery Product Picture

Figure 25. End-to-End Preclinical Discovery Product Picture

Figure 26. Target and Biomarker Package Product Picture

Figure 27. Global AI Target Discovery Platform Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Figure 28. Pharma Discovery Programs

Figure 29. Biotech Pipeline Development

Figure 30. Academic Translational Research

Figure 31. CRO and Discovery Services

Figure 32. Clinical Research and Precision Medicine

Figure 33. Government and Nonprofit Research

Figure 34. Others

Figure 35. AI Target Discovery Platform Report Years Considered

Figure 36. Global AI Target Discovery Platform Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 37. Global AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 38. Global AI Target Discovery Platform Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 39. Global AI Target Discovery Platform Revenue-Based Market Share by Region (2021-2032)

Figure 40. Global AI Target Discovery Platform Revenue-Based Market Share Ranking (2025)

Figure 41. Tier Distribution by Revenue Contribution (2021 vs 2025)

Figure 42. SaaS Software Platform Revenue-Based Market Share by Player in 2025

Figure 43. Enterprise-Deployed Platform Revenue-Based Market Share by Player in 2025

Figure 44. Collaborative Discovery Service Revenue-Based Market Share by Player in 2025

Figure 45. Data/API Subscription Revenue-Based Market Share by Player in 2025

Figure 46. Integrated AI + Wet-Lab Service Revenue-Based Market Share by Player in 2025

Figure 47. Global AI Target Discovery Platform Revenue-Based Market Share by Type (2021-2032)

Figure 48. Global AI Target Discovery Platform Revenue-Based Market Share by Data Foundation (2021-2032)

Figure 49. Global AI Target Discovery Platform Revenue-Based Market Share by Analytical Function (2021-2032)

Figure 50. Global AI Target Discovery Platform Revenue-Based Market Share by Project Scope (2021-2032)

Figure 51. Global AI Target Discovery Platform Revenue-Based Market Share by Application (2021-2032)

Figure 52. North America AI Target Discovery Platform Revenue YoY (US$ Million), 2021-2032

Figure 53. North America Top 5 Players AI Target Discovery Platform Revenue (US$ Million) in 2025

Figure 54. North America AI Target Discovery Platform Revenue (US$ Million) by Application (2021-2032)

Figure 55. US AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 56. Canada AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 57. Mexico AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 58. Europe AI Target Discovery Platform Revenue YoY (US$ Million), 2021-2032

Figure 59. Europe Top 5 Players AI Target Discovery Platform Revenue (US$ Million) in 2025

Figure 60. Europe AI Target Discovery Platform Revenue (US$ Million) by Application (2021-2032)

Figure 61. Germany AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 62. France AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 63. U.K. AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 64. Italy AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 65. Russia AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 66. Asia-Pacific AI Target Discovery Platform Revenue YoY (US$ Million), 2021-2032

Figure 67. Asia-Pacific Top 8 Players AI Target Discovery Platform Revenue (US$ Million) in 2025

Figure 68. Asia-Pacific AI Target Discovery Platform Revenue (US$ Million) by Application (2021-2032)

Figure 69. Indonesia AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 70. Japan AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 71. South Korea AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 72. Australia AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 73. India AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 74. Indonesia AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 75. Vietnam AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 76. Malaysia AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 77. Philippines AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 78. Singapore AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 79. Central and South America AI Target Discovery Platform Revenue YoY (US$ Million), 2021-2032

Figure 80. Central and South America Top 5 Players AI Target Discovery Platform Revenue (US$ Million) in 2025

Figure 81. Central and South America AI Target Discovery Platform Revenue (US$ Million) by Application (2021-2032)

Figure 82. Brazil AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 83. Argentina AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 84. Middle East and Africa AI Target Discovery Platform Revenue YoY (US$ Million), 2021-2032

Figure 85. Middle East and Africa Top 5 Players AI Target Discovery Platform Revenue (US$ Million) in 2025

Figure 86. Middle East and Africa AI Target Discovery Platform Revenue (US$ Million) by Application (2021-2032)

Figure 87. GCC Countries AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 88. Israel AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 89. Egypt AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 90. South Africa AI Target Discovery Platform Revenue (US$ Million), 2021-2032

Figure 91. AI Target Discovery Platform Value Chain Mapping

Figure 92. Channels of Distribution (Direct Vs Distribution)

Figure 93. Bottom-up and Top-down Approaches for This Report

Figure 94. Data Triangulation

Figure 95. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of AI Target Discovery Platform in 2032? zhanKai

The global market size of AI Target Discovery Platform in 2032 was 3147 Million USD.

What was the global market size of AI Target Discovery Platform in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global AI Target Discovery Platform market size from 2026 to 2032? shouQi

Which companies rank high in the global AI Target Discovery Platform market? shouQi

Related Reports

AI Target Discovery Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Target Discovery Platform was estimated to be worth US$ 654 million in 2025 and is projected to reach US$ 3147 million, growing at a CAGR of 25.0% from 2026 to 2032.
Published Date: 2026-07-24
Pages: 127
USD 3950.00
(Single User License)
Global AI Target Discovery Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Target Discovery Platform market size was US$ 654 million in 2025 and is forecast to reach a readjusted size of US$ 3147 million by 2032 with a CAGR of 25.0% during the forecast period 2026-2032.
Published Date: 2026-07-24
Pages: 128
USD 4250.00
(Single User License)
Global AI Target Discovery Platform Market Research Report 2026
The global AI Target Discovery Platform market was valued at US$ 654 million in 2025 and is anticipated to reach US$ 3147 million by 2032, at a CAGR of 25.0% from 2026 to 2032.
Published Date: 2026-07-24
Pages: 136
USD 2900.00
(Single User License)

AI Target Discovery Platform - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Target Discovery Platform was estimated to be worth US$ 654 million in 2025 and is projected to reach US$ 3147 million, growing at a CAGR of 25.0% from 2026 to 2032.
Published: 2026-07-24
Pages: 127
USD 3950.00 (Single User License)
Global AI Target Discovery Platform Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Target Discovery Platform market size was US$ 654 million in 2025 and is forecast to reach a readjusted size of US$ 3147 million by 2032 with a CAGR of 25.0% during the forecast period 2026-2032.
Published: 2026-07-24
Pages: 128
USD 4250.00 (Single User License)
Global AI Target Discovery Platform Market Research Report 2026
The global AI Target Discovery Platform market was valued at US$ 654 million in 2025 and is anticipated to reach US$ 3147 million by 2032, at a CAGR of 25.0% from 2026 to 2032.
Published: 2026-07-24
Pages: 136
USD 2900.00 (Single User License)